Speaker Details

Oliver J. Wisco, DO, FAAD

Oliver J. Wisco, DO, FAAD

Dermatology Health Specialists, PC

BIOGRAPHY

Dr. Wisco is a dermatologist, Mohs surgeon, clinical informaticist, health policy researcher, and educator whose work focuses on using data, informatics, and health system design to improve healthcare quality, access, and outcomes. He is the Founder and Director of the Brown University Healthcare Performance Measurement Lab and serves as adjunct faculty with the Brown Center for Biomedical Informatics, academic faculty in Brown University’s Master’s in Health Informatics & AI Program, and a Research Scientist in the Brown University Health Department of Dermatology. He previously served as Director of the Cutaneous Oncology Program at Brown University Health from 2020 through 2025. His research integrates healthcare performance measurement, clinical informatics, geospatial and population health analytics, data infrastructure, health services research, and clinical investigation. A central theme of Dr. Wisco’s work is translating academic expertise into practical and sustainable models of care, particularly for rural and underserved communities. He is the Founder, President, and CEO of Dermatology Health Specialists, an independent specialty care system based in Bend, Oregon, that extends dermatologic and surgical care throughout Central and Eastern Oregon. At Harney District Hospital in Burns, he established a dermatology clinic and Mohs surgery program, the first such services within approximately 120 miles. Through this clinical work and the nonprofit the Wisco Institute, he studies barriers to specialty care and develops models that use informatics, virtual collaboration, education, and regional partnerships to bring expertise closer to patients and local clinicians. He also leads and collaborates on investigator-initiated and industry-sponsored clinical research in cutaneous oncology. Dr. Wisco served for 26 years in the United States Air Force, Air National Guard, and Air Force Reserve, retiring at the rank of Colonel after serving in clinical, operational, and command roles. He has held academic appointments at Brown University, the Uniformed Services University of the Health Sciences, Oregon Health & Science University, Emory University School of Medicine, and Tulane University School of Medicine. Across his research, teaching, clinical practice, and organizational leadership, his overarching goal is to connect patients, clinicians, researchers, health systems, and communities through data and technology to create more equitable, effective, and sustainable systems of care.

SESSIONS

F053 A Primer and Practical Approach to Cancer Checkpoint Inhibitors for the Dermatologist
Mar 21, 2027 • 3:30 PM - 5:30 PM

DISCLOSURES

Castle Biosciences – Investigator(Fees); Natera – Advisory Board(Fees); Regeneron – Consultant (1099 relationship)(Fees), Investigator(Fees);